Democrats Press Pfizer on Chemotherapy Drug Shortages Democrats Press Pfizer on Chemotherapy Drug Shortages
Democratic legislators on the House Committee on Oversight and Reform have written a letter to Pfizer, requesting information on how the company is addressing shortages of chemotherapy drugs.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

The Unique Hell of Getting Cancer as a Young Adult
When I got diagnosed with Stage 3b Hodgkin Lymphoma at age 32, it was almost impossible to process. Without a family history or lifestyle risk factors that put cancer on my radar, I stared at the emergency room doctor in utter disbelief when he said the CT scan of my swollen lymph node showed what appeared to be cancer—and lots of it. A few days away from a bucket list trip to Japan, I’d only gone to the emergency room because the antibiotics CityMD prescribed to me when I was sick weren’t working.I didn’t want to be sick in a foreign country. So when the doctor told me of my diagnosis, the  on...
Source: TIME: Health - February 23, 2024 Category: Consumer Health News Authors: Maria Yagoda Tags: Uncategorized freelance Source Type: news

Oxaliplatin in Older Adults With Resected Colorectal Cancer? Oxaliplatin in Older Adults With Resected Colorectal Cancer?
Dr David Kerr discusses the use of adjuvant chemotherapy with oxaliplatin to high-risk patients with resected colorectal cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

New Drug to Treat Mesothelioma Hailed as a Major Breakthrough
ADI-PEG20 or pegargiminase is being hailed as the first drug of its kind to be incorporated successfully with chemotherapy in 20 years. Researchers say this new drug could bring hope to thousands of mesothelioma survivors and their families.  The drug blocks the cancer’s food supply, ensuring the disease can’t spread. It prevents cancer cells from absorbing the amino acid arginine from the bloodstream. Arginine helps the body build protein.  Mesothelioma cells are deficient in a protein called ASS1, which allows cells to create their own arginine. If the cancer cells can’t get arginine from blood, the...
Source: Asbestos and Mesothelioma News - February 21, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Clinical Trials/Research/Emerging Treatments Mesothelioma Source Type: news

Tagrisso With the Addition of Chemotherapy Approved in the US for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer
19 February 2024 -- AstraZeneca’s Tagrisso has been approved in the US for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). The approval... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 19, 2024 Category: Drugs & Pharmacology Source Type: news

FDA approves osimertinib with chemotherapy for EGFR-mutated non-small cell lung cancer
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 16, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Arginine Starvation Boosts OS in Mesothelioma
(MedPage Today) -- First-line chemotherapy plus an investigational arginine-depleting agent improved survival in nonepithelioid pleural mesothelioma compared with chemotherapy alone, a randomized trial showed. For the study's primary endpoint... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 16, 2024 Category: Hematology Source Type: news

Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC
(MedPage Today) -- Adding tislelizumab to neoadjuvant chemotherapy followed by adjuvant use of the investigational PD-1 inhibitor improved event-free survival (EFS) in resectable non-small cell lung cancer (NSCLC), a phase III trial from China... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 16, 2024 Category: Hematology Source Type: news

Tracing the Progress of Treatment Strategies in Diffuse Large B-Cell Lymphoma Tracing the Progress of Treatment Strategies in Diffuse Large B-Cell Lymphoma
Dr. Kami Maddocks explores the transformation of treatment approaches for DLBCL from chemotherapy-based strategies to targeted therapies.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 15, 2024 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news

Drug offers ‘wonderful’ breakthrough in treatment of asbestos-linked cancer
Medicine used alongside chemotherapy in trials quadrupled three-year survival rates for mesotheliomaScientists have developed a drug to treat mesothelioma, a notoriously hard-to-treat cancer linked to asbestos, in the biggest breakthrough in two decades.Thousands of people are diagnosed with the disease globally every year, which tends to develop in the lungs and ismainly caused by exposure to asbestos at work. It is aggressive and deadly, and has one of the world ’s worst cancer survival rates.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 15, 2024 Category: Science Authors: Andrew Gregory Health editor Tags: Cancer research Health Medical research Science Society Queen Mary, University of London UK news Source Type: news

US Agencies Start Inquiry Into Generic Drug Shortages
The F.T.C. and H.H.S. are examining the tactics of group purchasing organizations that generic industry executives say have led to scarce supplies of treatments like chemotherapy. (Source: NYT Health)
Source: NYT Health - February 14, 2024 Category: Consumer Health News Authors: Christina Jewett Tags: Shortages Drugs (Pharmaceuticals) Supply Chain Generic Brands and Products Chemotherapy Federal Trade Commission Health and Human Services Department Khan, Lina Source Type: news

Include Neoadjuvant Chemotherapy in Stage II-III Lung Cancer Include Neoadjuvant Chemotherapy in Stage II-III Lung Cancer
Mark Kris, MD, discusses the use of a checkpoint inhibitor and chemotherapy as neoadjuvant therapy for every patient with stage II and III lung cancer at the time of diagnosis.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 14, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Pembrolizumab Improves Event-Free Survival in Early NSCLC
TUESDAY, Feb. 13, 2024 -- For patients with early-stage non-small cell lung cancer (NSCLC), event-free survival (EFS) is improved with neoadjuvant pembrolizumab and chemotherapy, according to a study presented at the annual meeting of The Society of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 13, 2024 Category: Pharmaceuticals Source Type: news

FLT3 Inhibitor Highly Active in Newly Diagnosed Acute Myeloid Leukemia
(MedPage Today) -- Patients with newly diagnosed FLT3-mutated acute myeloid leukemia (AML) had a high response rate and prolonged event-free survival (EFS) following treatment with an investigational FLT3 inhibitor and chemotherapy, a preliminary... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 13, 2024 Category: Hematology Source Type: news

Early Detection Tests for Mesothelioma Are in Development
Scientists in Australia are developing early detection tests for mesothelioma. The Asbestos and Dust Diseases Research Institute’s new test could potentially save lives. According to ADDRI’s academic and research director Dr. Anthony Linton, the tests will be similar to PCR tests already in use to detect COVID-19. These new tests can find small amounts of DNA that cause disease. The PCR method, used since the 1980s, allows DNA samples to be studied in a higher level of detail. PCR is the tech behind the beginning of the 1990 Human Genome Project to identify and map human DNA.  “We have identified a...
Source: Asbestos and Mesothelioma News - February 13, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Asbestos Exposure Clinical Trials/Research/Emerging Treatments Doctors/Specialists Mesothelioma Source Type: news